Our People: Executive Team

Martin Burns

Martin Burns

Chief Executive Officer and a Managing Member

Martin spent more than 15 years as a management consultant in the US and Europe at Deloitte Consulting and PricewaterhouseCoopers. Martin has previously led corporate strategy, innovation, operations, quality and regulatory, M&A and global expansion assignments for medical device and life sciences companies.

Sammy Lai

Sammy Lai

Chief Financial Officer

Sammy has over 18 years of corporate finance and investment banking experience and has completed over $1 billion of transactions. Prior to Bruin, Sammy served as a senior finance executive at BancAssets, a financial services company, and FMG, a family office with operations in media, gaming, retail, and real estate. Sammy has also served as a senior investment banker at Libra Securities and Innovation Capital, and he began his career as an analyst at Lazard Asset Management and Merrill Lynch. He graduated from Harvard University with an A.B. in Economics and is a Chartered Financial Analyst (CFA).

Sara Barrington

Sara Barrington

Executive Vice President of Business Operations

Sara joined us from Exosome Diagnostics, where she was SVP, Finance from 2008-2014. Previously, she served as Chief Financial Officer of Creative Technology Group, Inc from 2005-2008 and was Chief Financial Officer of AusAM Biotechnologies from 2001-2005. Ms. Barrington held several positions from 1997-2000 at British Telecom in both finance and marketing in New Business Development. She received a B.A. from Lancaster University, England and holds post-graduate degrees with the Institute of Chartered Accountants of England and Wales and the Chartered Institute of Marketing (U.K.).

Rachael Lester

Rachael Lester

Vice President of Product

Rachael brings over 15 years of life sciences experience to BBI. With various roles in Marketing, R&D, and Finance, Rachael has launched over 6 new biopharmaceutical and medical device products. Most recently, Rachael served as Global Head of Strategic Asset Management at Onyx Pharmaceuticals, prior to its acquisition by Amgen.  Previously, Rachael has held Marketing roles at Pfizer, and was a management consultant at Deloitte Consulting, where she served as the West Coast lead for Life Sciences Commercial Strategy & Operations. Rachael received her MBA from Kellogg School of Management and B.A. from the University of Pennsylvania. 

Colin Priestley

Colin Priestley

EMEA Managing Director

Colin has 30 year's experience in the healthcare marketplace operating mainly in the medical device sector through direct and distribution business channels. Colin's work has essentially concentrated on business start up, recovery, integration and development through new product introduction. Throughout his career, Colin has demonstrated strong leadership, direction and management resulting in successful business outcomes, most recently as a business consultant with Real Healthcare Solutions. He has been directly involved in the Wound Care sector since 2008 and has worked with global organisations such as Smith & Nephew and KCI Medical.

Dr. Graham Ross

Dr. Graham Ross

Vice President of Research & Development

Graham has spent his career bringing the future to life, designing everything from spacecraft to inkjet printer cartridges.  With more than 35 years in R&D, and still having a slide rule to prove it, his breadth of experience ranges from world-class companies such as Hewlett Packard and Lockheed Martin to a small telecommunications start-up, including 8 years at Cardinal Health developing healthcare products.  Graham received his PhD in Mechanical Engineering from Stanford University and is also a Patent Agent registered to practice before the U.S. Patent and Trademark Office.

Mark Bruns

Mark Bruns

Vice President of Sales

Mark brings over 30 years of sales experience in the medical device industry to the BBI team. He has previously served as an executive sales leader for Alaris Medical Systems, Cardinal Health and CareFusion, where he directed sales strategy, operations, training and clinical support. Mark has previously led the transformation of medical technology businesses resulting in revenue growth of $250M to $1B and market share increases of 24% to 50%.

Sally Grigoriev

Sally Grigoriev

Senior Advisor of Operations

Sally has over 25 years of R&D, Quality, Regulatory, Manufacturing, and Operations experience within the medical device industry. She was formerly Senior Vice President of Manufacturing and Operations at CareFusion and Cardinal Health.

FaLang translation system by Faboba